Belfer Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$310K Buy
1,162
+41
+4% +$11.1K 5.19% 8
2025
Q4
$281K Sell
1,121
-122
-10% -$32.4K 4.93% 9
2025
Q3
$357K Hold
1,243
4.95% 8
2025
Q2
$326K Sell
1,243
-96
-7% -$23.4K 4.99% 11
2025
Q1
$312K Buy
1,339
+23
+2% +$5.58K 5.41% 11
2024
Q4
$294K Hold
1,316
4.68% 11
2024
Q3
$294K Hold
1,316
4.76% 11
2024
Q2
$268K Hold
1,316
5.05% 10
2024
Q1
$288K Buy
1,316
+6
+0.5% +$1.32K 5.18% 11
2023
Q4
$298K Hold
1,310
6.29% 6
2023
Q3
$263K Sell
1,310
-215
-14% -$45.3K 6.82% 7
2023
Q2
$316K Hold
1,525
8.39% 5
2023
Q1
$300K Buy
1,525
+134
+10% +$27.6K 7.78% 4
2022
Q4
$281K Hold
1,391
9.63% 5
2022
Q3
$245K Buy
+1,391
New +$285K 8.98% 5

Other funds holding LH

Belfer Management's LH Position: Q1 2026 in Review

Belfer Management increased its Labcorp (LH) stake by 3.7% in Q1 2026, buying an estimated $11.1K and bringing the position to 1,162 shares worth $310K. The position accounts for 5.19% of the portfolio, ranked #8.

Belfer Management first reported a position in LH in Q3 2022 and has held it in 15 quarters since. The position peaked at $357K in Q3 2025. 1,032 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Belfer Management held 1,162 shares of Labcorp worth $310K as of Q1 2026.
  • Belfer Management bought 41 Labcorp shares in Q1 2026, an estimated $11.1K.
  • Labcorp made up 5.19% of Belfer Management's portfolio in Q1 2026, its #8 holding.
  • Belfer Management first reported a position in Labcorp in Q3 2022 and has held it in 15 quarters since.
  • Belfer Management's Labcorp position peaked at $357K in Q3 2025.
  • 1,032 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Belfer Management's 13F filing for Q1 2026, filed 8 May 2026.